Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that measuring hair density, shaft diameter, growth rate, and anagen:telogen ratio is important for assessing hair growth treatments.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Francisco Camacho Martinez has made significant contributions to skin and sexually transmitted diseases, developed surgical techniques, but is concerned about patient survival rates and over-specialization in dermatology.

Using platelet-rich plasma, basic fibroblast growth factor, and minoxidil together significantly increases hair count and growth rate in people with hair loss.

The document concludes that we need more research to understand Telogen Effluvium and find effective treatments.

Dog hair grows back in about 14 weeks after being clipped for surgery, and the season doesn't really affect this growth rate.

Weight loss can cause temporary hair loss, especially in women and older adults.

The document concludes that more research is needed to confirm if blood tests for things like iron and vitamin D are helpful for hair loss from Telogen effluvium.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Ginsenoside F2 from ginseng may increase hair growth better than standard treatments by affecting cell growth signals.

More people, especially Hispanic/Latinx, in certain NYC communities experienced temporary hair loss during the COVID-19 pandemic.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

COVID-19 may cause temporary hair loss in some people.

Monocytes might be linked to hair loss after COVID-19.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

People with telogen effluvium often have much lower vitamin D levels than healthy individuals.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

Congenital triangular alopecia can occur outside the typical fronto-temporal region.

During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.

Cudrania tricuspidata and Sargassum fusiforme extracts improved hair growth in mice by affecting growth-related genes.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.